Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world
Novartis and the Bill and Melinda Gates Foundation are joining forces to discover and develop…
Category: Biotech
STAT+: FDA warns AcelRx of misleading ads for its pain drug Dsuvia
The manufacturer of Dsuvia, a pain drug approved by the Food and Drug Administration amid…
STAT+: After a controversial Alzheimer’s drug review, FDA’s Woodcock rejects proposal to ‘firewall’ agency and drug companies
In response to criticism, a top Food and Drug Administration official maintained that creating a…
STAT+: STAT+ Conversations: A conversation on race, science, and advocacy with Black in Neuro founder Angeline Dukes
Editor’s Note: A livestream of the conversation will be embedded below at 12 p.m. ET….
.jpg)
STAT+: Pharmalittle: WHO approves AstraZeneca Covid-19 vaccine; North Korean hackers target Pfizer vaccine data
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Bristol Myers and Sanofi ordered to pay $834 million to Hawaii for withholding Plavix label
After years of litigation, a Hawaii court judge ordered Bristol Myers Squibb (BMY) and Sanofi…
Q&A: How the U.S. can respond to coronavirus variants, and prepare for future evolution
Coronavirus variants are here. Now what? A new report from infectious disease experts provides policy…
Bluebird suspends studies of sickle cell gene therapy following cancer diagnoses in two more treated patients
Bluebird Bio said Tuesday that it has suspended clinical trials involving its gene therapy for…
Once again, senators want GAO to probe the role of PBMs in prescription drug pricing
In a bid to contain prescription drug prices, a pair of U.S. senators is re-introducing…
STAT+: Moncef Slaoui, departing Warp Speed, raises $250 million to test his R&D philosophy in a new company
Moncef Slaoui, who headed the Operation Warp Speed vaccine-development effort under the Trump administration, is…
Opinion: 3 ways the life sciences industries can eliminate bias in AI
Advances in the life sciences over the past decade have made it possible to manipulate…
Opinion: With the first dose, I need to be at peace with the vaccine. And let my body do the work
I normally arrive at the hospital thinking about protecting my patients. Today it was all…
As the pandemic ushered in isolation and financial hardship, overdose deaths reached new heights
Among the unrelenting death statistics flowing from the CDC last month, one grim non-Covid-19 statistic…
STAT+: At Flagship Pioneering, the brazen venture capital firm that bankrolled Moderna, there’s a tolerance for failure but not for weakness
Not long ago, the name Flagship Pioneering was as likely to elicit an eye roll…
STAT+: Soaring mental health unicorns race to meet employer needs
Companies scrambling to provide employees with expanded mental health care options are propping up a…
Opinion: The NIH needs to ensure that women are equally represented in grant funding decisions
For U.S. researchers, the room where it happens —”it” being decisions about funding — is…
The search for new Covid drugs — and a researcher’s reason for optimism
David Fajgenbaum is a physician and scientist at the University of Pennsylvania. He is best…
STAT-Harris Poll: 1 in 4 Americans were unable to get a Covid-19 test when they wanted one
As the U.S. struggles to contain the Covid-19 pandemic, nearly a quarter of Americans say…
Opinion: A monument to our monumental suffering can help America heal from this pandemic
In the 56 weeks since the first case of Covid-19 was reported in the United…
Opinion: A monument to our monumental suffering can help America heal from this pandemic
In the 56 weeks since the first case of Covid-19 was reported in the United…
STAT+: Pharmalittle: An arthritis drug reduced Covid-19 death rates; impatience grows over choosing FDA commissioner
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Experts encouraged by Denali’s early results in study of Hunter syndrome drug
A preliminary study of a medicine developed by Denali Therapeutics to treat Hunter syndrome, a…
Opinion: With Covid-19 vaccines, ‘fair’ isn’t always fair enough
The success of Operation Warp Speed in delivering two effective Covid-19 vaccines in record time…
Opinion: The hazards of medicine by tweet: the case of anti-cytokine therapy for Covid-19
Positive news about a potential Covid-19 treatment — a drug that blocks the receptor for…
Opinion: Dear NHS: You need a control arm for Grail’s cancer test
A simple blood test able to detect 50 different cancers is the grail of cancer…
By looking the other way, pharma money helped fuel a toxic political atmosphere in the U.S.
As the impeachment trial for former President Trump plays out, the pharmaceutical industry can thank…
Overloaded schedules and ‘Covid cowbells’: For pharmacists, the Covid-19 vaccine rollout brings exhaustion, but some relief
The nationwide frenzy to get Covid-19 vaccines has been complicated, frustrating, and downright exhausting for…
Listen: The state of the pandemic, the hunt for Covid-19 drugs, & meme stocks in biotech
When will we have enough vaccine doses? How many effective Covid-19 drugs are just waiting…
STAT+: Amicus drug for Pompe disease falls short in key clinical trial, but company will push for approval
Amicus Therapeutics said Thursday that its drug for patients with Pompe disease, a rare genetic…
Studying Neanderthal mini-brains, scientists unlock clues to modern human evolution
Hoping to learn what sets our brains apart from those of the Neanderthals, scientists have…
STAT+: With a legislative veto, Maryland’s prescription drug affordability board moves forward
Following a vote by the Maryland House of Delegates, the state now has all the…
STAT+: Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
As the world charges to vaccinate the population against the coronavirus, gene therapy developers are…
Arthritis drug cuts deaths in hospitalized Covid-19 patients, major study shows
Tocilizumab, a drug usually used to treat rheumatoid arthritis, reduced the rate for death in…
STAT+: Pharmalittle: Teva and Merck may help with Covid-19 vaccine production; $5 billion Gilead deal goes up in flames
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Drug maker agrees to plead guilty to hiding and destroying records before FDA inspection
A unit of Fresenius Kabi, a major supplier of infused and intravenously administered drugs, has…
STAT+: Zocdoc, staking its future on the promise of hybrid care, raises $150 million
Less than a year since Zocdoc reinvented itself as a telehealth platform in the face…
STAT+: Investing in Pacific Biosciences, SoftBank pays a 540% premium to offer price for entire company
SoftBank, the Japanese tech conglomerate famous for paying questionable sums to invest in startups, has…
Opinion: A public option for health insurance could be a disaster, especially in times of crisis
In a step to help more Americans get health insurance, President Biden signed an executive…
Opinion: It’s time to fast track innovation in medical devices for children
When a baby arrived at Children’s National Hospital with a critically underdeveloped heart, it was…
Could AI tools for breast cancer worsen disparities? Patchy public data in FDA filings fuel concern
The great hope of artificial intelligence in breast cancer is that it can distinguish harmless…
STAT+: ‘A natural experiment’: Pandemic-driven drop in cancer screening may aid research on overdiagnosis
It’s counterintuitive, but catching cancer early isn’t always for the best. And the coronavirus pandemic…
Covid-19 vaccination rates follow the money in states with the biggest wealth gaps, analysis shows
The affluent town of Woodbridge, Conn., has less than half the population of neighboring Ansonia,…
STAT+: Drug maker will slash prices on cancer medicines to end price gouging probe in Europe
After months of deliberation, the European Commission has accepted an offer from Aspen Pharma to…
STAT+: Gilead’s Galapagos deal disintegrates, a black mark for CEO O’Day
The $5 billion deal that Gilead CEO Daniel O’Day presented as his signature move shortly…
STAT+: Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
Equip, a startup providing virtual therapy for eating disorders, raises $13 million
A vanguard of virtual behavioral health startups are attracting investor interest. The latest: Equip, which…
Opinion: America’s addiction crisis, compounded by Covid-19, requires immediate action to save lives
Despite hard-fought progress in recent years, new data from the Centers for Disease Control and…
Opinion: Back to ‘normal’ isn’t good enough
With the anticipation of increasing distribution of Covid-19 vaccines, Americans are looking forward to a…
Opinion: Do the math: Vaccines alone won’t get us out of this pandemic
As Covid-19 vaccines are being rolled out across the U.S., Americans seem to be heaving…
CDC director says ‘bruises are going to take a long time to heal’ at agency
The new director of the Centers for Disease Control and Prevention acknowledged that morale at…